Publications by authors named "Mahmud İslam"
Aim: BK polyomavirus infection is a challenging complication of renal transplantation. The management is not standardized and is based on reports from transplantation centers' experiences, usually with small sample sizes. Therefore, we aimed to present our countrywide experience with BK virus nephropathy (BKVN) in renal transplant recipients.
View Article and Find Full Text PDFIntroduction: Peritoneal dialysis (PD) remains understudied in disaster nephrology. This retrospective multicenter study explores the experiences of PD survivors following the February 6, 2023, Kahramanmaraş Earthquake.
Methods: Adult PD patients from 11 affected cities were analyzed to assess challenges faced during and postearthquake, alongside clinical outcomes.
Objective: Temporary vascular access is mandatory for acute hemodialysis. Heparin lock solution is the standard of care worldwide. Many lock solutions were studied in terms of thrombosis and catheter-related infection prevention, but none replaced heparin as a standard measure.
View Article and Find Full Text PDFIntroduction: With increased fluid intake and tolvaptan treatment, the growth rate of cysts can be theoretically decelerated in autosomal polycystic kidney disease. In this prospective study, it was planned to evaluate thirst sensation in these patients and the parameters affecting its intensity.
Methods: Forty-one ADPKD patients on tolvaptan and 40 ADPKD patients not on tolvaptan as the control group were evaluated for thirst distress sensation and intensity.
Background: This study aims to investigate whether fetuin A deficiency predicts the prognosis of COVID-19 disease in kidney transplant recipients (KTRs).
Method: The study was conducted on 35 hospitalized KTRs with COVID-19 pneumonia between November 2020 and June 2021. Serums were collected for fetuin-A measurement at admission and after six months of follow-up.
Article Synopsis
- A study examined the role of monocyte chemoattractant protein (MCP-1) levels as a potential biomarker for COVID-19 progression in kidney transplant patients, comparing those hospitalized with COVID-19 to those without.
- The analysis involved 89 kidney transplant patients, and while some differences in inflammation indicators were observed between groups, MCP-1 levels did not correlate with COVID-19 severity or patient survival.
- Ultimately, the findings suggest that MCP-1 is not a reliable indicator for predicting COVID-19 outcomes in kidney transplant recipients.
Article Synopsis
- IgA nephropathy (IgAN) and minimal change disease (MCD) are the most frequently reported glomerular diseases following COVID-19 vaccinations, especially mRNA vaccines, along with others like membranous nephropathy.
- A global registry was created to collect anonymized data on patients with glomerular diseases suspected after vaccination, focusing on vaccination details, kidney function, and treatment outcomes.
- Results show that while IgAN and MCD have a better chance of kidney function recovery and reduced proteinuria within 4–6 months post-vaccination, causality remains unproven despite a temporal link.
Background: Several guidelines recommend using the Clinical Frailty Scale (CFS) for triage of critically ill coronavirus disease 2019 (COVID-19) patients. This study evaluates the impact of CFS on intensive care unit (ICU) admission rate and hospital and ICU mortality rates in hospitalized dialysis patients with COVID-19.
Methods: We analysed data of dialysis patients diagnosed with COVID-19 from the European Renal Association COVID-19 Database.
Background: In the general population with coronavirus disease 2019 (COVID-19), obesity is associated with an increased risk of mortality. Given the typically observed obesity paradox among patients on kidney function replacement therapy (KFRT), especially dialysis patients, we examined the association of obesity with mortality among dialysis patients or living with a kidney transplant with COVID-19.
Methods: Data from the European Renal Association COVID-19 Database (ERACODA) were used.
Article Synopsis
- Acute kidney injury (AKI) is common in COVID-19 patients, leading to severe outcomes; this study explored factors affecting in-hospital outcomes in patients with both conditions.
- The study evaluated 578 hospitalized COVID-19 patients with AKI, identifying their characteristics and renal outcomes from 34 hospitals in Turkey, with data collected from March to June 2020.
- Findings revealed a median patient age of 69, high rates of comorbidities like hypertension and diabetes, and that worse renal outcomes correlated with higher AKI stages; the overall in-hospital mortality rate was 38.9%.
Objective: Older adults with co-morbidities have been reported to be at higher risk for adverse outcomes of coronavirus disease 2019 (COVID-19). The characteristics of COVID-19 in older patients and its clinical outcomes in different kidney disease groups are not well known.
Methods: Data were retrieved from a national multicentric database supported by Turkish Society of Nephrology, which consists of retrospectively collected data between 17 April 2020 and 31 December 2020.
Background/aim: Hospital-acquired acute kidney injury (HA-AKI) may commonly develop in Covid-19 patients and is expected to have higher mortality. There is little comparative data investigating the effect of HA-AKI on mortality of chronic kidney disease (CKD) patients and a control group of general population suffering from Covid-19.
Materials And Methods: HA-AKI development was assessed in a group of stage 3–5 CKD patients and control group without CKD among adult patients hospitalized for Covid-19.
Purpose: Patients on maintenance hemodialysis are vulnerable to viral infections like COVID-19 because of the low chance of obedience and complying with rules besides the need for transfer to distant dialysis facilities. We investigated the impact and clinical effect of treatment of COVID-19 in dialysis patients.
Methods: We included patients on maintenance hemodialysis at different healthcare facilities in Zonguldak city.
Background: Chronic kidney disease (CKD) and immunosuppression, such as in renal transplantation (RT), stand as one of the established potential risk factors for severe coronavirus disease 2019 (COVID-19). Case morbidity and mortality rates for any type of infection have always been much higher in CKD, haemodialysis (HD) and RT patients than in the general population. A large study comparing COVID-19 outcome in moderate to advanced CKD (Stages 3-5), HD and RT patients with a control group of patients is still lacking.
View Article and Find Full Text PDFBackground: Patients on kidney replacement therapy comprise a vulnerable population and may be at increased risk of death from coronavirus disease 2019 (COVID-19). Currently, only limited data are available on outcomes in this patient population.
Methods: We set up the ERACODA (European Renal Association COVID-19 Database) database, which is specifically designed to prospectively collect detailed data on kidney transplant and dialysis patients with COVID-19.